1902 - MM CAR-T to Upgrade Response

Go Back to BMT CTN Protocol Listing

  • Protocol Short Name and Number: MM CAR-T to Upgrade Response, 1902
  • Protocol Long Name: Phase II Multicenter Trial of anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for Multiple Myeloma Patients with Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation and Maintenance Lenalidomide
  • Protocol (PDF)
  • ICFs (PDF)
  • FAQs (PDF)
  • Key Personnel
    • BMT CTN # 1902 Co-Chair: Sergio Giralt, MD
    • BMT CTN # 1902 Co-Chair: Alfred Garfall, MD
    • BMT CTN # 1902 Protocol Sponsor: Marcelo Pasquini, MD
    • BMT CTN # 1902 Protocol Coordinator: Erica Anderson; bmtctn1902@emmes.com
  • Keywords: Multiple Myeloma, MM, Autologous Hematopoietic Cell Transplant, Auto Transplant, Autologous Transplant, Auto, HCT, HSCT, Anti-B Cell Maturation Antigen, BCMA, CAR-T, CAR T, CART, bb2121